DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Neuronal SignalingNeuronal Signaling
  5. /P2X ReceptorP2X Receptor
  6. /FilapixantFilapixant
Chemical structure of CAS 1948232-63-0

Filapixant

In Stock•Starting at $591 for 1 mg•Purity ≥ 98.78%
CAS No.1948232-63-0
MDL No.N/A
MFC24H26F3N5O3S
MW521.60
InChI KeyMROBUJILSMBILX-FOIQADDNSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98.78%$591In Stock
5 mg98.78%$1504In Stock
10 mg98.78%$2419In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1948232-63-0
Product NameFilapixant
Heavy Atom Count36Rotatable Bond Count7
Atom Stereo Count2Bond Stereo Count0
HBA8HBD1
TPSA89.470 ŲCharge0
Exact Mass521.17085Complexity1202.45
pKa9.247XLogP4.128

Related Articles

Studies related to this compound and its mechanism of action

Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending-dose study in healthy young men.

British journal of clinical pharmacology • Vol. 90, Issue 8 • 2024
PMID: 38775025DOI: 10.1111/bcp.16091

The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial.

Respiratory research • Vol. 24, Issue 1 • 2023
PMID: 37041539PMC: PMC10088222DOI: 10.1186/s12931-023-02384-8

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact